Jun 2, 2026 08:41AM
May 27, 2026 06:50AM
May 13, 2026 06:51AM
May 12, 2026 07:05AM
Apr 7, 2026 04:31PM
Apr 6, 2026 08:38AM
Apr 2, 2026 06:43AM Unicycive Therapeutics (UNCY) PT Lowered to $40 at Guggenheim
Apr 1, 2026 06:59AM
Mar 30, 2026 07:05AM
Jan 29, 2026 09:15AM
Jan 29, 2026 07:05AM
Jan 29, 2026 07:05AM
Dec 29, 2025 07:05AM
Dec 29, 2025 07:05AM Unicycive Therapeutics Announces Resubmission of New Drug Application (NDA) for Oxylanthanum Carbonate (OLC)
Dec 2, 2025 12:39PM
Nov 12, 2025 08:36AM
Nov 12, 2025 07:05AM
Oct 28, 2025 07:06AM
Oct 28, 2025 07:05AM
Jun 11, 2025 06:38AM
Jun 10, 2025 06:02AM Unicycive Therapeutics (UNCY) Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat
Jun 10, 2025 06:00AM
May 21, 2025 08:48AM
May 14, 2025 07:15AM
Apr 10, 2025 09:14AM
Apr 10, 2025 08:00AM
Apr 1, 2025 07:00AM
Apr 1, 2025 06:46AM Unicycive Therapeutics (UNCY) PT Raised to $7.50 at H.C. Wainwright
Mar 31, 2025 07:00AM
Mar 13, 2025 07:00AM
Feb 20, 2025 07:02AM
Feb 20, 2025 07:00AM
Jan 28, 2025 07:02AM
Jan 28, 2025 07:00AM
Jan 7, 2025 07:01AM Unicycive Therapeutics (UNCY) Announces Publication of Positive Oxylanthanum Carbonate (OLC) Dose Escalation Data in Clinical and Translational Science
Jan 7, 2025 07:00AM
Dec 17, 2024 07:00AM
Nov 21, 2024 07:00AM
Nov 13, 2024 07:15AM
Nov 12, 2024 07:52AM
Nov 11, 2024 07:01AM
Nov 11, 2024 07:00AM Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease o
Sep 7, 2024 08:00PM
Sep 4, 2024 07:27AM
Sep 3, 2024 07:03AM
Sep 3, 2024 07:03AM

15,422 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All